OBSOLETE: Rare genetic palpebral, lacrimal system and conjunctival disease

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:183598
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

This Orphanet entry (code 183598) is classified as 'OBSOLETE,' meaning it is no longer used as an active disease category. It was previously a broad grouping term for rare genetic conditions that affect the eyelids (palpebral), the tear-producing and tear-draining system (lacrimal system), and the conjunctiva (the thin clear tissue that covers the white part of the eye and lines the inside of the eyelids). Because this was a general classification rather than a single specific disease, it has been retired and replaced by more precise disease entries in medical databases. Conditions that once fell under this umbrella category include various inherited disorders causing droopy eyelids (ptosis), abnormal eyelid development, blocked or absent tear ducts, dry eyes, and conjunctival abnormalities. Each of these specific conditions now has its own classification with more detailed information about causes, symptoms, and treatments. If you or a family member has been given a diagnosis that references this obsolete category, it is important to work with your doctor or a clinical geneticist to identify the specific condition involved. A more precise diagnosis will help guide appropriate genetic testing, treatment options, and long-term management. Your medical team can look up the current Orphanet classification that best matches your symptoms and genetic findings.

Key symptoms:

Droopy eyelids (ptosis)Blocked or absent tear ductsDry eyes or excessive tearingAbnormal eyelid shape or positionRed or irritated eyesSensitivity to lightRecurrent eye infectionsSwelling around the eyesDifficulty closing the eyes completelyAbnormal growths on the conjunctiva

Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for OBSOLETE: Rare genetic palpebral, lacrimal system and conjunctival disease.

View clinical trials →

No actively recruiting trials found for OBSOLETE: Rare genetic palpebral, lacrimal system and conjunctival disease at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the OBSOLETE: Rare genetic palpebral, lacrimal system and conjunctival disease community →

No specialists are currently listed for OBSOLETE: Rare genetic palpebral, lacrimal system and conjunctival disease.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to OBSOLETE: Rare genetic palpebral, lacrimal system and conjunctival disease.

Search all travel grants →NORD Financial Assistance ↗

Community

Open OBSOLETE: Rare genetic palpebral, lacrimal system and conjunctival diseaseForum →

No community posts yet. Be the first to share your experience with OBSOLETE: Rare genetic palpebral, lacrimal system and conjunctival disease.

Start the conversation →

Latest news about OBSOLETE: Rare genetic palpebral, lacrimal system and conjunctival disease

No recent news articles for OBSOLETE: Rare genetic palpebral, lacrimal system and conjunctival disease.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.This category is listed as obsolete — what is the specific, current diagnosis for my condition?,What gene or genes might be involved, and should we pursue genetic testing?,What are the treatment options for my specific condition, and are any of them curative?,How often should I or my child have eye examinations?,Are there risks to vision that we should watch for over time?,Should other family members be evaluated or tested?,Can you refer me to a specialist or center with experience in this specific condition?

Common questions about OBSOLETE: Rare genetic palpebral, lacrimal system and conjunctival disease

What is OBSOLETE: Rare genetic palpebral, lacrimal system and conjunctival disease?

This Orphanet entry (code 183598) is classified as 'OBSOLETE,' meaning it is no longer used as an active disease category. It was previously a broad grouping term for rare genetic conditions that affect the eyelids (palpebral), the tear-producing and tear-draining system (lacrimal system), and the conjunctiva (the thin clear tissue that covers the white part of the eye and lines the inside of the eyelids). Because this was a general classification rather than a single specific disease, it has been retired and replaced by more precise disease entries in medical databases. Conditions that once